The first drug therapy approved for diabetic macular edema (DME) and diabetic retinopathy (DR) in patients with DME 1

DME

DR in patients with DME

Dosing and Safety

Resources

Resources for your patients.

LUCENTIS Direct

Simple, personalized ordering.

LUCENTIS Co-pay Card Program

Support for your patients with commercial insurance.

LUCENTIS Access Solutions

Access and reimbursement services for your patients.